Spotlight

 

It turns out, they like us, or so they say. Biomedical researchers should take note that for the second year in a row, U.S. Senate appropriators have declared funding the National Institutes of Health a...

 

When presenting to the Congressional Biomedical Research Caucus (CBRC), you want to best represent the work...

CBRC Briefings

Are There Pharmaceutical Drugs That Can Treat Au...

Mark Bear
March 30, 2011

Dr. Bear from the Massachusetts Institute of Technology briefs the Congressional biomedical Research Caucus. He suggests that a specific class of drug already sitting on drug company shelves may help patients with an inherited disease called Fragile X syndrome, a common cause of autism—though he is quick to caution that years of research still remain. Dr. Bear highlights his over four decades of research that has culminated in a deep udeep understanding of the mechanisms responsible for whittling away inappropriate synaptic connections. Insights derived from this line of research have recently suggested the remarkable possibility of new treatments for genetic disorders associated with autism and intellectual impairment.

H1N1 Influenza (Swine Flu): Where We Stand

Peter Palese
September 22, 2010

Dr. Peter Palese of the Mount Sinai School of Medicine in New York briefs the Congressional Biomedical Research Caucus on H1N1 Influenza (Swine Flu): Where We Stand. For 40 years, Dr. Palese has researched influenza’s various strains. He and his colleagues recognize that, although the burden of seasonal influenza is significant, the threat of a pandemic like that of 1918, which caused 750,000 deaths in the U.S. alone, is most concerning. Watch Dr. Palese as he discusses how outbreaks of novel influenza virus strains are unpredictable and thus we must prepare to be able to respond to an emergency by: (1) strengthening the surveillance system; (2) improving vaccine design, manufacture and delivery, as well as the regulatory climate for influenza virus vaccines; (3) supporting research on novel antivirals; and (4) having a robust public health service in place.

The Science of Jet Lag and its Management

Charmane Eastman
September 15, 2010

Watch Dr. Charmane Eastman of Rush University Medical Center in Chicago brief the Congressional Biomedical Research Caucus on The Science of Jet Lag and its Management. Dr. Eastman explains, using simple principles of circadian rhythms, why we get jet lag and why it is usually more severe after flying east than west. She will also highlight strategies to reduce and to eliminate jet lag using bright light, melatonin, and gradually shifting sleep schedules will be presented. All of these principles and procedures will be illustrated using the example of a commercially available flight from Washington DC, to Baghdad, with a stop in Munich.